Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
British Journal of Haematology
|
February 11, 2020
Real-world outcomes of post-transplant lymphoproliferative disorder treated with risk-stratified sequential therapy
Christin B DeStefano
Journal of the National Cancer Institute
|
June 22, 2026
RE: Deployment to Karshi-Khanabad Air Base, Uzbekistan between 2001 and 2005 and subsequent risk of specific cancers among US service members
Christin B DeStefano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2019
Second Chances
Christin B DeStefano
Cancer
|
March 20, 2026
The myeloma divide: How sex and age shape disease characteristics
Christin B DeStefano, Wendy Cozen
Military Medicine
|
May 21, 2024
Incident Rate Limitations in Retrospective Observational Military Cancer Research
David R Sayers, Christin B DeStefano
Therapeutic Advances in Hematology
|
May 2, 2018
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice
Christin B DeStefano, Christopher S Hourigan
American Journal of Hematology
|
August 9, 2024
Are veterans at increased risk of myeloproliferative neoplasms?
Christin B DeStefano, Nicholas Burwick, Drew A Helmer
American Journal of Hematology
|
July 14, 2022
Insane in the membrane: A case of hereditary spherocytic pyropoikilocytosis
Steven J Gibson, Theodosia A Kalfa, Christin B DeStefano
Transfusion
|
April 23, 2026
Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship
Christin B DeStefano, Jeremy Perkins, Wendy Cozen, et al.
Current Cancer Drug Targets
|
April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic Implications
Sachi Horibata, George Alyateem, Christin B DeStefano, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
British Journal of Haematology
|
February 11, 2020
Real-world outcomes of post-transplant lymphoproliferative disorder treated with risk-stratified sequential therapy
Christin B DeStefano
Journal of the National Cancer Institute
|
June 22, 2026
RE: Deployment to Karshi-Khanabad Air Base, Uzbekistan between 2001 and 2005 and subsequent risk of specific cancers among US service members
Christin B DeStefano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2019
Second Chances
Christin B DeStefano
Cancer
|
March 20, 2026
The myeloma divide: How sex and age shape disease characteristics
Christin B DeStefano, Wendy Cozen
Military Medicine
|
May 21, 2024
Incident Rate Limitations in Retrospective Observational Military Cancer Research
David R Sayers, Christin B DeStefano
Therapeutic Advances in Hematology
|
May 2, 2018
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice
Christin B DeStefano, Christopher S Hourigan
American Journal of Hematology
|
August 9, 2024
Are veterans at increased risk of myeloproliferative neoplasms?
Christin B DeStefano, Nicholas Burwick, Drew A Helmer
American Journal of Hematology
|
July 14, 2022
Insane in the membrane: A case of hereditary spherocytic pyropoikilocytosis
Steven J Gibson, Theodosia A Kalfa, Christin B DeStefano
Transfusion
|
April 23, 2026
Clarifying transfusion-associated graft-versus-host disease risk in modern Hodgkin lymphoma survivorship
Christin B DeStefano, Jeremy Perkins, Wendy Cozen, et al.
Current Cancer Drug Targets
|
April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic Implications
Sachi Horibata, George Alyateem, Christin B DeStefano, et al.
Page
of 3